	Integration of donor microbiota following FMT correlates with anti-PD-1 response in melanoma. Nat Commun Fessler JL, Olm MR, Engleman EG, Sonnenburg JL. PMID: 42218119 [PubMed - as supplied by publisher]
	Time of day of neoadjuvant immune checkpoint inhibitor administration is associated with survival but not pathological response in resectable stage III-IV melanoma: A retrospective cohort study. Eur J Cancer Nelson A, Alghaib S, Björkström K, Isaksson K, Krabbe E, Orme S, Kadefors M, Wallander M, Bjursten S, Ullenhag GJ, Carneiro A, Helgadottir H, Ny L, Olofsson Bagge R. PMID: 42218102 [PubMed - as supplied by publisher]
	Malignant melanoma presenting as a cavernous malformation: systematic literature review and report of 4 illustrative cases. World Neurosurg Nico E, Nikolov NK, Saggi S, Hackett AM, Koester SW, Eberle AT, Hartke JN, Malnik SL, Fox BM, Winkler EA, Catapano JS, Eschbacher JM, Lawton MT. PMID: 42217571 [PubMed - as supplied by publisher]
	Diagnostic performance and clinical limitations of sentinel lymph node biopsy in head and neck melanoma: a 20-year retrospective cohort study. J Cancer Res Clin Oncol Lükewille L, Wiegand S, Fazel A, Kähler KC, Radecker G, Hoffmann M, within the HANSEATIC Head and Neck Oncology Collaboration. PMID: 42217063 [PubMed - indexed for MEDLINE]
	Uveal melanoma: A review of current treatment limitations and the emerging therapeutic potential of natural killer cells. J Invest Dermatol Narayana RVL, Lanier AL, Wajapeyee N, Gupta R. PMID: 42216948 [PubMed - as supplied by publisher]
	A Primary Care Intervention to Improve Melanoma Detection and Management. J Am Board Fam Med Verdieck A, Berry E, Holderness H, Haroon A, Danna MN, Erroba J, Leachman S, Hodes T, Latour E, Stoos E, Cohen D, Flocke S. PMID: 42215050 [PubMed - indexed for MEDLINE]
	Canonical and noncanonical heterotrimeric G-protein signaling in uveal melanoma: Established mechanisms and emerging spindle-orientation hypotheses. Biochem Pharmacol Woodard GE, Jardín I, Rosado JA. PMID: 42214764 [PubMed - as supplied by publisher]
	The Impact of a Regional Community of Practice to Improve Quality of Melanoma Care: Setting Guidelines for Preoperative Diagnostic Imaging in Early-Stage Melanoma. Ann Surg Oncol Aw K, Lau R, Wong B, Riad K, Lee A, Li H, Grose E, Brandts-Longtin O, Abed A, Stevenson J, Sheikh R, Chen R, Goulet C, Johnson-Obaseki S, Nessim C. PMID: 42213260 [PubMed - as supplied by publisher]
	ESR Essentials: imaging of melanoma-practice recommendations by the European Society of Oncologic Imaging. Eur Radiol Kunz WG, Bonaffini PA, Zamboni GA, Cappello G, Leithner D, Mayerhoefer ME. PMID: 42213112 [PubMed - as supplied by publisher]
	Prognostic value of BAP1 expression in uveal melanoma: a comparative study with histopathological factors in a large Spanish cohort. Front Oncol Valencia Nieto P, García Álvarez C, García Lagarto ME, Muñoz Moreno MF, Diezhandino García P, Saornil Álvarez MA. PMID: 42211514 [PubMed]
	Analysis of therapeutic strategy changes for patients with melanoma using a national dataset in Japan. Int J Clin Oncol Goto H, Bito T, Kawai R, Hiroyasu S, Ihara Y, Goto M, Shintani A, Tsuruta D. PMID: 42209932 [PubMed - as supplied by publisher]
	Intramedullary or invasive characteristics of spinal melanocytomas: a PRISMA compliant systematic review and pooled case analysis. J Neurooncol Leon S, Maity A, Gluski J, Brown EDL, Elsamadicy AA, Santangelo G, Lo SF, Sciubba DM. PMID: 42209927 [PubMed - indexed for MEDLINE]
	Functional surgery for invasive nail apparatus melanoma: A cohort study and systematic review. Eur J Surg Oncol Lee ES, Park JH, Lee DY, Mun GH, Lee KT. PMID: 42208343 [PubMed - as supplied by publisher]
	AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response. Eur J Cancer Schuiveling M, van Duin IAJ, Ter Maat LS, van der Weerd JC, Verheijden RJ, van den Berkmortel F, Blank CU, Breimer GE, Burgers FH, Boers-Sonderen M, Labots M, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, Simkens L, Westgeest HM, Schrader AMR, Pluim JPW, van Diest PJ, Blokx WAM, Veta M, Suijkerbuijk KPM. PMID: 42208280 [PubMed - as supplied by publisher]
	Amelanotic choroidal melanoma mimicking central serous chorioretinopathy: a diagnostic challenge. Eye (Lond) Meng Y, Li J, Li T. PMID: 42203985 [PubMed - as supplied by publisher]
	Temporal trends in the probability of melanoma diagnosis in four Nordic countries, 1973-1999. Cancer Causes Control Moro O, Schopf TR, Veierød MB, Sebastiani G. PMID: 42201376 [PubMed - indexed for MEDLINE]
	Diagnostic and Prognostic Values of PRAME Immunohistochemistry in Acral Lentiginous Melanoma. Am J Dermatopathol Triyangkulsri K, Wittayabusarakam N, Smitthisakda S, Sakpuwadol N, Thadanipon K, Phruttinarakorn B, Rutnin S. PMID: 42200754 [PubMed - as supplied by publisher]
	The immune landscape of melanoma microenvironmental crosstalk. Front Immunol Yang Q, Yang Q, Xu B, Chen X, Zheng H, Wang M, Zhang W, Wu J, Cheng H. PMID: 42199415 [PubMed - indexed for MEDLINE]
	Evolutionarily Optimized Multi-Scale Gabor Modeling of Directional Lesion Texture in Dermoscopic Images for Interpretable Melanoma Classification. Diagnostics (Basel) Santiago-Montero R, Calzada-Ledesma V, Gutiérrez-Hernández DA, Ortiz-Aguilar LM, Mares-Castro A, Xoca-Orozco LA, Flores-Sierra JJ. PMID: 42196797 [PubMed]
	Dynamic Time-Resolved Remodeling of the Immune Microenvironment After Resistance to BRAF/MEK Inhibitors in Melanoma: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies. Int J Mol Sci Meng W, Liu Y, Zhang H, Wang M, Mu X, Zhang Z, Tie Y. PMID: 42196460 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 45716

Page 1 of 2286



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy